Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease
- DOI
- 10.2215/cjn.0000001041
- Published
- 2026-03-18
- Container
- Clinical Journal of the American Society of Nephrology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2215/cjn.0000001041,
title = {Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease},
author = {Wan-Chuan Tsai and Hon-Yen Wu and Yu-Sen Peng},
year = {2026},
journal = {Clinical Journal of the American Society of Nephrology},
doi = {10.2215/cjn.0000001041},
url = {https://doi.org/10.2215/cjn.0000001041}
}RIS
TY - JOUR TI - Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease AU - Wan-Chuan Tsai AU - Hon-Yen Wu AU - Yu-Sen Peng PY - 2026 JO - Clinical Journal of the American Society of Nephrology DO - 10.2215/cjn.0000001041 UR - https://doi.org/10.2215/cjn.0000001041 ER -
APA
Tsai, W., Wu, H., & Peng, Y. (2026). Addressing Disparity: Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001041
Source records
- crossref · retrieved 2026-09-25T05:53:44.048Z